NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/23/2023
Back to search
Official data from USPTO
QVEKLY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
QVEKLY
ST13
US500000088360418Class
5, 9, 10
Filing
88360418
Registration
7057988
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
05/23/2023
Trademark type
Word
Nice classes
5, 9, 10
Filing date
03/28/2019
Registration date
05/23/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/23/2023
Last transaction
05/23/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Hellerup, DK
Examiner
LORENZO, GEORGE
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Ascendis Pharma Endocrinology Division A/S
Representatives
Shannon Marie McKeon DYKEMA GOSSETT PLLC
Technical classification
Nice Classes
Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of growth disorderspharmaceutical preparations for the treatment of endocrine disorderspharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical usediagnostic preparations for identifying and detecting growth hormone deficiencyendocrine disordersbone disorderscancerinfectious diseases
Class 9
Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatmentpatient assistance and health insurance in the field of growth disordersendocrine disordersbone disorderscancerinfectious diseases; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersa downloadable software application for sharing information related to growth disordersendocrine disordersbone disorderscancerinfectious diseases and the treatment of growth disordersendocrine disordersbone disorderscancerinfectious diseases for use by patients with growth hormone disordershypoparathyroidismskeletal dysplasiadiabetes in the medical field of growth disordersendocrine disordersbone disorderscancerinfectious diseases; downloadable computer application software for mobile phonestablet computers handheld computers and personal computersdownloadable software that coordinates the delivery of health care services between health care providerspatients and those parties responsible for the payment of health care servicesdownloadable software that allows individuals seeking medical educationinformation and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersdownloadable software that enables health care providers to monitor patientscommunicate clinical information relevant to a patient's careprovide and exchange information concerning patients and the health care services provided to patients; downloadable softwaredownloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable softwaredownloadable software applications and downloadable mobile applications for the measurement of heightweightblood pressureserum calciumblood glucoseheart rate; downloadable softwaredownloadable software applications and downloadable mobile applications for providingexchangingretrieving and analyzing health and healthcare information; downloadable software for medical purposesfor formattingviewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersa downloadable software application for providing healthcare-related informationmedication reminderstracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of growth disordersendocrine disordersbone disorderscancerinfectious diseases
Class 10
Medical devices for injectiondosage and control of pharmaceuticalsmedical devices for injectiondosage measurement and monitoring of pharmaceuticals for the treatment of growth disordersendocrine disordersbone disorderscancerinfectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical usesyringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disordershypoparathyroidismskeletal dysplasiacancer and diabetes; medical apparatusinfusion and injection devices for administering drugs; medical apparatus for diagnostic purposesmedicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic
Publications
History of USPTO decisions and trademark events.
55 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/23/2023
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
04/20/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
04/13/2023
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
04/13/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/26/2022
EX5G
SOU EXTENSION 5 GRANTED
10/25/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/17/2022
EXT5
SOU EXTENSION 5 FILED
10/07/2022
EEXT
SOU TEAS EXTENSION RECEIVED
10/07/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/14/2022
EX4G
SOU EXTENSION 4 GRANTED
04/12/2022
EXT4
SOU EXTENSION 4 FILED
04/12/2022
EEXT
SOU TEAS EXTENSION RECEIVED
04/12/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/16/2021
EX3G
SOU EXTENSION 3 GRANTED
09/14/2021
EXT3
SOU EXTENSION 3 FILED
09/14/2021
EEXT
SOU TEAS EXTENSION RECEIVED
09/14/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/14/2021
EX2G
SOU EXTENSION 2 GRANTED
04/12/2021
EXT2
SOU EXTENSION 2 FILED
04/12/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/12/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/15/2020
EX1G
SOU EXTENSION 1 GRANTED
10/13/2020
EXT1
SOU EXTENSION 1 FILED
10/13/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/13/2020
DOCK
ASSIGNED TO EXAMINER
06/04/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/14/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/18/2020
PUBO
PUBLISHED FOR OPPOSITION
02/18/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/29/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/13/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/13/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/13/2020
ALIE
ASSIGNED TO LIE
01/07/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/16/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/13/2019
GNSL
LETTER OF SUSPENSION E-MAILED
09/13/2019
CNSL
SUSPENSION LETTER WRITTEN
09/13/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/04/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/12/2019
GNSL
LETTER OF SUSPENSION E-MAILED
06/12/2019
CNSL
SUSPENSION LETTER WRITTEN
06/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
06/12/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/12/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
06/12/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/12/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/11/2019
GNRT
NON-FINAL ACTION E-MAILED
06/11/2019
CNRT
NON-FINAL ACTION WRITTEN
06/11/2019
DOCK
ASSIGNED TO EXAMINER
06/09/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/15/2019
NWAP
NEW APPLICATION ENTERED
04/01/2019
Continuous trademark protection
Get notified about every new filing that threatens QVEKLY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.